Blood cell labelling. Theory and methods: radiation hazards.
The chief physical properties of the radionuclide In111 are outlined, and compared with those of three other radionuclides, Tc99m, I131 and Cr51 which have similar applications. It is pointed out that the gamma-rays of In111 are appreciably more penetrating in lead than those of Tc99m and the significance of this, both in the use of shielding on syringes and in the effectiveness of lead glass screens is discussed. Examples are given of the dosimetry for In111 labelled cells in humans and it is noted that the absorbed dose in the spleen per mCi (37 MBq) injected may be some 10 rad (0.1 Gy). The problems that have been noted of damage to cells arising from oxine labelling and now considered to be due to radiation damage are briefly reviewed.
D001773:Blood Cells / Q000000981:diagnostic imaging* / Q000187:drug effects; D002860:Chromium Radioisotopes / Q000009:adverse effects; D006801:Humans; D007204:Indium / Q000009:adverse effects; D007553:Isotope Labeling; D011829:Radiation Dosage; D011832:Radiation Injuries; D011868:Radioisotopes / Q000009:adverse effects; D011877:Radionuclide Imaging; D013667:Technetium / Q000009:adverse effects
D002860:Chromium Radioisotopes; D011868:Radioisotopes; D007204:Indium; D013667:Technetium